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Objective: Administration of glucagon (GCG) or GCG-containing co-agonists reduces body weight and increases energy expenditure. These
actions appear to be transduced by multiple direct and indirect GCG receptor (GCGR)-dependent mechanisms. Although the canonical GCGR is
expressed in brown adipose tissue (BAT) the importance of BAT GCGR activity for the physiological control of body weight, or the response to GCG
agonism, has not been deﬁned.
Methods: We studied the mechanisms linking GCG action to acute increases in oxygen consumption using wildtype (WT), Ucp1/ and Fgf21/
mice. The importance of basal GCGR expression within the Myf5þ domain for control of body weight, adiposity, glucose and lipid metabolism, food
intake, and energy expenditure was examined in GcgrBAT/ mice housed at room temperature or 4 C, fed a regular chow diet (RCD) or after a
prolonged exposure to high fat diet (HFD).
Results: Acute GCG administration induced lipolysis and increased the expression of thermogenic genes in BAT cells, whereas knockdown of
Gcgr reduced expression of genes related to thermogenesis. GCG increased energy expenditure (measured by oxygen consumption) both in vivo
in WT mice and ex vivo in BAT and liver explants. GCG also increased acute energy expenditure in Ucp1/ mice, but these actions were partially
blunted in Ffg21/ mice. However, acute GCG administration also robustly increased oxygen consumption in GcgrBAT/ mice. Moreover, body
weight, glycemia, lipid metabolism, body temperature, food intake, activity, energy expenditure and adipose tissue gene expression proﬁles were
normal in GcgrBAT/ mice, either on RCD or HFD, whether studied at room temperature, or chronically housed at 4 C.
Conclusions: Exogenous GCG increases oxygen consumption in mice, also evident both in liver and BAT explants ex vivo, through UCP1-
independent, FGF21-dependent pathways. Nevertheless, GCGR signaling within BAT is not physiologically essential for control of body
weight, whole body energy expenditure, glucose homeostasis, or the adaptive metabolic response to cold or prolonged exposure to an energy
dense diet.
 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The proglucagon-derived peptides (PGDPs) are encoded by a single
mammalian gene and include glucagon (GCG), oxyntomodulin, gli-
centin, and two GCG-like peptides, GLP-1 and GLP-2 [1]. The PGDPs
control energy intake, gut motility, mucosal integrity, and the ab-
sorption, disposal and storage of ingested energy. The prototype
member of the PGDP family, 29 amino acid GCG, is produced in and
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production [2e4].
GCG exerts its metabolic actions through a single GCG receptor (GCGR)
[5] highly expressed in hepatocytes but also detected in brain, heart,
kidney, gastrointestinal tract, and both white and brown adipose tissue
(WAT and BAT, respectively) [6,7]. Although less extensively studied,
GCG exerts direct actions on adipose tissue, encompassing increased
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Original Articleincreased oxygen consumption in WAT and BAT [8e12]. In addition,
GCG administration also acutely increases whole body oxygen con-
sumption following administration to animals and humans in vivo [13e
15].
Considerable evidence links sustained GCG administration to the
reduction of food intake, enhancement of energy expenditure and
weight loss in rodent and human studies [16e18]. Moreover, patients
presenting with GCG-producing tumors frequently manifest severe
weight loss, through mechanisms that are incompletely understood
[19]. Despite several decades of experimentation, the precise pro-
cesses and cell types contributing to GCG-mediated weight loss remain
incompletely understood. Although intracerebroventricular infusion of
GCG directly reduces food intake [20] and increases energy expendi-
ture [21], other studies have demonstrated that the GCG-mediated
reduction of food intake requires intact hepatic vagal nerve innerva-
tion [22] and rats with surgical BAT denervation exhibit diminished
metabolic and mitochondrial responses to exogenous glucagon [23].
The clinical development of investigational GCG-containing multi-ag-
onists, including oxyntomodulin and its derivatives [3,24,25], for the
treatment of diabetes and obesity has rekindled interest in whether and
how GCGR signaling results in BAT activation and increased energy
expenditure [2,26,27]. Several studies invoke an indirect role for GCG
on BAT and energy expenditure, acting through enhanced blood ﬂow
[28], the sympathetic nervous system (SNS) [29,30], or ﬁbroblast
growth factor (FGF)21 [31,32]. However, other studies support a direct
role for GCG as an activator of oxygen consumption in BAT [14,33].
Interestingly, GCG infusion in healthy humans subjected to cold
exposure increased energy expenditure without evidence for BAT
activation as assessed by positron emission tomography scanning
[15].
Here we examined the importance of the BAT GCGR for GCG-
stimulated energy expenditure in mice and characterized the meta-
bolic phenotype of mice with genetic deletion of the Gcgr in BAT using
myogenic factor 5 (Myf5)-Cre. Using BAT cells and explants ex vivo, as
well as WT and knockout mice, we demonstrate that GCG acts both
directly and indirectly to enhance whole body and BAT oxygen con-
sumption. Nevertheless, the BAT Gcgr is physiologically dispensable
for GCG-stimulated increase in energy expenditure, and the adaptive
metabolic responses to HFD feeding or prolonged cold exposure.
2. MATERIALS AND METHODS
2.1. Animals
All animal experiments were conducted in accordance with protocols
approved by the Toronto Centre for Phenogenomics (TCP) Animal Care
Committee. Experiments were performed in group-housed male mice
that were maintained on a 12h light/dark cycle at room temperature
(RT; 21 C), 4 C, or 30 C and with free access to food and water,
except where indicated. Mice were fed either a standard rodent chow
diet (RCD; 18% kcal from fat, 2018 Harlan Teklad, Mississauga, ON) or
a high-fat diet (HFD; 45% kcal from fat, D12451i, Research Diets, New
Brunswick, NJ) for diet-induced obesity analysis. Chronically housed
(w12 weeks) 4 C group-housed male mice were placed into non-
vented microisolator cages (Ancare) with free access to food and
water and transferred into environmentally controlled enclosures
(Betatech Inc.) at 8e10 weeks of age with an ambient temperature of
initially 16 C. The ambient temperatures within the enclosures were
decreased by 2 C every day until 4 C ambient temperature was
established.
GcgrBAT/ (BAT-speciﬁc Gcgr knockout) mice and controls (Cre,
Floxed) were generated by crossing hemizygous Myf5-Cre mice38 MOLECULAR METABOLISM 22 (2019) 37e48  2019 The Authors. Published by Elsevier GmbH. T(007893, The Jackson Laboratory, Bar Harbour, ME) with ﬂoxed Gcgr
mice [34,35]. Experiments were carried out in all groups of male mice
(unless otherwise stated) that were on a C57BL/6J background.
However, because the control groups were phenotypically similar with
respect to body weight, fat mass, and glucose homeostasis, all control
data are presented as a single pooled group (Myf5-Cre and Gcgrﬂox/ﬂox
mice). Mice were euthanized by CO2 inhalation, and tissues were
immediately frozen in liquid nitrogen or placed in tissue cassettes for
histology analysis. Whole-body Ucp1/ (003124) mice were pur-
chased from The Jackson laboratory. Whole-body Fgf21/
(Fgf21tm1.1Djm) mice were provided by Steven A. Kliewer [36].
2.2. Body composition using MRI (magnetic resonance imaging),
food intake, indirect calorimetry and ex vivo respirometry
Body composition was measured after 32 weeks on RCD or HFD using
an Echo MRI nuclear magnetic resonance system (Echo Medical
Systems, Houston, TX). Food intake was quantiﬁed (over 72 hrs) at 8e
10 and 30e32 weeks of age in mice housed individually in cages
containing pre-weighed amounts of food. Food intake data in this
paper are shown from mice maintained on diet for 30e32 weeks. After
16e18 weeks on RCD or HFD, mice were subjected to indirect calo-
rimetry experiments to measure oxygen consumption, carbon dioxide
production, respiratory exchange ratio, activity, and energy expendi-
ture (kcal/h) using a Comprehensive Lab Animal Monitoring System
(CLAMS; Columbus Instruments, Columbus OH). For measuring GCG-
induced oxygen consumption measurements, mice were fasted for
w4 h, anesthetized with sodium pentobarbital (60 mg/kg), and placed
on a heating pad for 10 mins prior to transferring them into a CLAMS
chamber where they were acclimatized for w 8 mins and subse-
quently given ip injections of vehicle control (acidiﬁed PBS) followed by
GCG (0.01, 0.1, or 0.5 mg/kg, Sigma, Oakville, ON) or vehicle control
followed by GCG (0.5 mg/kg, Sigma), and CL316,243 (1.0 mg kg,
Sigma), a selective b-3-adrenergic receptor agonist. For basal ex vivo
oxygen consumption measurements, fresh tissues were extracted
from mice after CO2 asphyxiation and immediately placed into warm
(37 C) DMEM (4.5 g/l glucose, L-glutamine, Wisent, St. Bruno, QC)
buffer. Tissues were weighed (w10e20 mg), washed in ﬁltered
respiration buffer (PBS, 0.02% fatty acid free BSA, 25 mM glucose,
0.01% (vol/vol) of 100 mM Na pyruvate (Sigma)), minced with scissors,
re-suspended in respiration buffer and placed into a Mitocell chamber
(MT200A, Strathkelvin Instruments, North Lanarkshire, Scotland) with
a Clark electrode (Strathkelvin). For each tissue, measurements were
obtained from three separate depots of equivalent size. Recordings
were normalized to tissue weight. For stimulated ex vivo oxygen
consumption measurements, tissues were extracted from littermate
micew20e30 minutes after an acute injection of either PBS or GCG
(0.5 mg/kg, Sigma).
2.3. Glucose, insulin and lipid tolerance tests
All metabolic tests were performed after a 4e5 h fast. Blood was
collected via the tail vein for measuring insulin, GLP-1, GIP, GCG, tri-
glycerides, and FGF21 at indicated time points. For oral and intra-
peritoneal glucose tolerance tests (oGTT and ipGTT, respectively), D-
Glucose (1.5 g/kg; Sigma, Oakville, ON) was administered by oral
gavage (oGTT) or ip injection (ipGTT). During insulin tolerance tests
(ITT), animals fed a RCD received a single ip injection of 0.7 U/kg BW
insulin (Humalog, VL7510, Eli Lily, Scarborough, ON), whereas animals
fed a HFD received 1.0 U/kg BW of insulin. When mice were housed at
4 C, all animals were given a single ip injection of 0.35 U/kg BW of
insulin. Blood glucose was measured from the tail vein using a hand-
held glucose monitor (Contour, Bayer, Mississauga, ON)) before andhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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15, 30, 45, 60, 90, and 120 min post-glucose gavage or insulin in-
jection. For lipid tolerance tests (LTT), animals received a 200 ml oral
gavage of olive oil (Sigma) at time 0 and blood samples were collected
before and 1, 2, and 3 h after gavage.
2.4. Blood collection
All blood samples (w50e100 ml) during metabolic tests were
collected from tail vein into lithium coated Microvette tubes (Sarstedt,
Numbrecht, Germany) and mixed with a 10% volume of TED (5000 kIU/
ml Trasylol (Bayer), 32 mM EDTA, and 0.01 mM Diprotin A (Sigma)).
Samples were kept on ice and plasma was collected by centrifugation
(>12, 000 rpm at 4 C for 5 minutes) and stored at - 80 C.
2.5. Hormone and enzymatic assays
Plasma insulin (Ultrasensitive Mouse Insulin ELISA, Cat# 80-
INSMSU-E01 Alpco Diagnostics, Salem, NH), total GLP-1 (Meso
Scale Diagnostics, Cat# K150JVC-2 Rockville, MD), GIP (Crystal
Chem, Cat# 81517, Elk Grove Village, IL), and GCG (Mercodia,
Cat#10-1281-01) levels were assessed in plasma samples collected
before (time 0) and 10 mins post glucose or insulin administration
during metabolic tests. Plasma was assayed for non-esteriﬁed fatty
acids (NEFAs) using the NEFA-HR (2) kit (Wako Diagnostics, Cat#
999-34691, 995-34791, 991-34891, 993-35191, 276-76491,
Mountain View, CA) or triglycerides (TGs) using the Trig-GB kit (Cat#
05171407, calibrator 11877771216, Roche, Mississauga, ON). For
determination of TGs in tissue, frozen iBAT samples were weighed
(10e20 mg) and TGs were extracted using a 2:1 chloroform-
methanol solution and quantiﬁed with Trig-GB kit (Roche). Plasma
FGF21 (Millipore, Cat# EZRMFGF21-26K, Billerica, MA) levels were
assayed in fasted (4 h) 8 week old mice fed a RCD.
2.6. RNA isolation and gene expression assays
Tissue samples were homogenized in Tri Reagent (Molecular
Research Center, Cincinnati, ON) using a TissueLyser II system
(Qiagen, Germantown, MD), and total RNA was extracted using the
manufacturer’s protocol. First strand cDNA was synthesized from
DNase I-treated total RNA using the SuperScript III and random
hexamers (Thermo Fisher Scientiﬁc, Markham, ON). Gene expression
levels were quantiﬁed by real-time PCR using a QuantStudio System
and TaqMan Gene Expression Master Mix and Assays (Thermo Fisher
Scientiﬁc). Primer/probes were purchased from Thermo Fisher Sci-
entiﬁc and are listed in Supplementary Table 1. qPCR data were
analyzed by 2-DDCt method, and expression levels for each gene
were normalized to either Actb (b-actin) or Tbp (TATA-box-binding
protein).
2.7. Detection of full-length mouse Gcgr mRNA transcripts
Full-length (w1.4 kb) mouse Gcgr PCR products were ampliﬁed from
cDNA using the following primers: forward 50-CTG CTG CTG CTG CTG
TTGG -30 and reverse 50-ACC TTG GGA GAC TAC TGGC-30, separated
on an agarose gel, transferred to a nylon membrane, and hybridized
overnight with an internal 32P-labeled mouse Gcgr-speciﬁc oligonu-
cleotide probe (50-AAT GCC ACC ACA ACC TAA GC-3’-). The membrane
was washed and then imaged using a Storm 860 Phosphor Screen and
Quantity One imaging software (Bio-Rad, Hercules, CA). Actb was used
as a control for RNA integrity of samples.
2.8. Cell culture: BAT cell line
Immortalized BAT cells were a gift from Dr. Bruce Spiegelman’s lab-
oratory (Department of Cancer Biology, Dana-Farber Cancer Institute,
Boston, MA) [37]. On Day 0, BAT preadipocyte cells were plated ontoMOLECULAR METABOLISM 22 (2019) 37e48  2019 The Authors. Published by Elsevier GmbH. This is an open ac
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(4.5 g/l glucose, L-glutamine, Wisent, St. Bruno, QC) with 20% FBS
(Wisent), 1% Sodium Pyruvate (100 mM, Sigma),<0.01% HEPES (1M,
Wisent), and 1% Penicillin-Strep (Wisent)) and grown until they ach-
ieved a healthy mono-layer (w90e95% conﬂuent). After reaching
conﬂuence, on Day 1, growth media was replaced with induction
media (DMEM with 10% FBS, 1% Sodium Pyruvate, HEPES and 1%
Penicillin-Strep supplemented with 2 mg/ml dexamethasone (Sigma),
0.5 mM 3-isobutyl-1-methylxanthine (IBMX; Sigma), 125 mM indo-
methacin (Sigma), 10 mg/ml or 1.7 mM insulin (Sigma), and 1 nM T3
(Sigma). After 48 h of induction, on Day 3, media was changed to
maintenance media (DMEM (25 mM glucose) with 10% FBS, 1%
Sodium Pyruvate, <0.01% HEPES, and 1% Penicillin-Strep supple-
mented with 10 mg/ml or 1.7 mM insulin and 1 nM T3, (Sigma), until
cells were fully differentiated by Day 7. Fresh media was added to cells
as required. All experiments, unless otherwise stated, were performed
on fully differentiated cells on Day 7.
To assess the effects of GCG on gene expression or lipolysis, BAT cells
were differentiated for 7 days in collagen coated 12-well cell culture
dishes (initiated at a density of 40,000 cells per well) in 1 ml of growth
media. On Day 7, cells were nutrient-media starved for 3 h in FBS-free
DMEM media devoid of all supplements except sodium pyruvate and
HEPES. For gene expression assay, BAT cells in each well were
treated with media (1 ml) containing either acidiﬁed PBS or GCG
100 nM for 1 or 4 h and RNA was isolated by adding 1 ml of Tri-
reagent directly into plates and homogenizing cells by repetitive
pipetting. For analysis of lipolysis, BAT cells were serum starved for
3 h. Media was then changed to warm (37 C) ﬁltered Kreb’s buffer
(12 mM Hepes, 121 mM NaCl, 4.9 mM KCL, 1.2 mM MgSO4,
0.33 mM CaCl2, 3% BSA, 3 mM glucose) containing either acidiﬁed
PBS or GCG (10 nM- 1 mM) for 2 h. Media was then collected into
1.5 ml Eppendorf tubes and frozen at 20 C. Free glycerol in cell
media was measured using a free glycerol assay kit (Cat# F6428,
Sigma), and normalized to protein content (measured using Bradford
assay kit (Bio-Rad, Montreal, QC).
2.9. siRNA-induced knockdown of Gcgr mRNA in BAT cells
On Day 0, BAT cells were plated at a density of 80,000 cells per well
in 6-well tissue culture dishes containing growth media. Cells were
differentiated as described above until Day 4, when differentiated
BAT cells were trypsinized, centrifuged and re-suspended in
antibiotic-free maintenance media. Differentiated BAT cells were
transfected with siRNA duplexes (Universal scrambled negative
control (Origene, Rockville, MD) sequence, Cat# SR30004-
CGUUAAUCGCGUAUAAUACGCGUAT) or Gcgr (Origene duplex
sequence, Cat# SR415672A-GGAGAAGCCAUGUUAUCUAUGAACT))
diluted in OptiMEM to a ﬁnal concentration of 50 mM in 1 ml of
media using Lipofectamine RNAiMAX Reagent (Thermo Fisher Sci-
entiﬁc), following the manufacturer’s protocol. Transfection com-
plexes were added to collagen coated 12-well plates containing
800,000e1,000,000 cells per well suspended in antibiotic-free
maintenance media. Maintenance media was replaced every 24 h
until Day 7 when cells were harvested for RNA isolation as described
above.
2.10. Histological analysis
Adipose tissues were ﬁxed in 10% buffered formalin for a minimum of
48 h, and then tissues were transferred into 70% ethanol until pro-
cessing. Samples were parafﬁn-embedded, sectioned at 4 mm
thickness, slide-mounted, and stained with hematoxylin and eosin.
Sections were scanned using the ScanScope CS System (Aperiocess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 39
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using ScanScope Software (Aperio Technologies).
2.11. Statistics
Data are represented as the mean  SEM. Statistical signiﬁcance was
determined by one-way ANOVA (post-hoc test Bonferroni), two-way
ANOVA (post-hoc test Tukey), paired (Figure 2D and Figure S2C) or
unpaired two-tailed Student’s t-test using GraphPad Prism version 8
Software (San Diego, CA). A p value < 0.05 was considered statisti-
cally signiﬁcant.
3. RESULTS
3.1. Gcgr mRNA transcripts are expressed at low levels in BAT and
GCG directly increases thermogenic gene expression and lipolysis in
a BAT cell line
Gcgr mRNA transcripts were detected by quantitative real time PCR in
adipose tissue depots (Figure 1A) including mesenteric white adipose
tissue (mWAT), inguinal (iWAT), epididymal (eWAT), retroperitoneal
(rWAT), and interscapular brown adipose tissue (iBAT) (Figure 1A),
corresponding to full length Gcgr mRNA (Figure 1B), albeit at levels
1,000e10,000 fold lower than in liver (Figure 1A). Gcgr mRNA was
also detected in a differentiated BAT cell line (Figure S1A), associated
with induction of Ucp1 expression (Figure S1B). GCG treatment
increased levels of Ucp1, Ppargc1a, and Cepba mRNA in BAT cellsFigure 1: Gcgr is expressed in adipose tissue and GCG administration increases th
(relative to levels in liver) in tissues from 20 week-old WT mice fed a RCD, n ¼ 4. (B) PCR
full length (w1.4 kb) Gcgr mRNA transcript in the liver and adipose tissue; Actb PCR o
thermogenic/lipolytic genes in BAT cells (differentiated for 7 days) 1 h after exposure to
representative of 3 independent experiments. (D) Basal mRNA transcript levels in differen
housekeeping gene for relative mRNA expression levels. (E) Free glycerol release from differ
(Fsk, positive control). mWAT ¼ mesenteric white adipose, iWAT ¼ inguinal WAT, eWAT
tissue, N.D. ¼ not detectable. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
40 MOLECULAR METABOLISM 22 (2019) 37e48  2019 The Authors. Published by Elsevier GmbH. Tstudied at Day 2 of differentiation (Figure S1C) and Ucp1, Ppargc1a,
Cidea, Elovl3, Ptgs2, and Fgf21 mRNA transcripts were increased by
GCG on Day 7 (Figure 1C). Conversely, siRNA-mediated knockdown of
Gcgr expression reduced levels of Ucp1, Ppargc1a, Elovl3, Cebpa,
Cidea, Lipe, Ardb3, and Fgf21 mRNA transcripts after 2 or 7 days of
differentiation (Figure 1D and Figure S1D). CL316,243 was adminis-
tered to BAT cells in a separate experiment, demonstrating selective
induction of mRNA transcripts in response to adrenergic activation
(Figure S1E). GCG also directly increased lipolysis in a dose-dependent
manner in BAT cells (Figure 1E), through mechanisms requiring the
Gcgr (Figure S1F). Hence, BAT cells express a functional canonical
GCGR directly coupled to thermogenic gene expression and lipolysis.
3.2. GCG increases oxygen consumption through UCP1-
independent, FGF21-dependent pathways
Considerable evidence demonstrates that acute GCG administration
rapidly increases circulating levels of FGF21 in mice and humans
[31,38]. Indeed, acute GCG administration increased oxygen con-
sumption in mice through mechanisms requiring hepatic farnesoid X
receptor signaling and FGF21 [32]. We observed that GCG (0.01e
0.5 mg/kg) administration rapidly increased oxygen consumption in a
dose-dependent manner in RCD-fed WT mice housed at RT (Figure 2A
and Figure S2A-B) and in mice fed a HFD (Figure S2C). GCG also
increased oxygen consumption in WT mice acclimatized to either cold
(4 C, Figure 2B) or thermoneutral (30 C, Figure 2C) temperatures forermogenic genes and lipolysis in BAT cells. (A) qPCR analysis of Gcgr expression
and Southern blot analysis using Gcgr-speciﬁc internal oligonucleotide probe detected a
f the same samples was used as a control (w0.3 kb). (C) mRNA transcript levels of
GCG (100 nM) expressed relative to levels in cells treated with PBS. The data are
tiated BAT cells transfected with scrambled control or Gcgr siRNA. Tbp was used as a
entiated BAT cells in response to a 2 h exposure of increasing doses of GCG or forskolin
¼ epididymal WAT, rWAT ¼ retroperitoneal WAT, iBAT ¼ interscapular brown adipose
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: GCG increases oxygen consumption in vivo and ex vivo, through UCP1-independent and FGF21-dependent pathways. (A) Oxygen consumption following an
acute injection of PBS or GCG (0.5 mg/kg) in 8e12 week old WT mice fed a RCD and housed at (A) room temperature (RT,w21 C), (B) 4 C, or (C) 30 C fed a HFD for 2 weeks,
n ¼ 4e6. (D) Oxygen consumption measured in ex vivo in iBAT obtainedw 20e30 minutes after ip administration of PBS or GCG (0.5 mg/kg) to 12 week old WT mice fed a RCD
and housed at RT, n ¼ 6. (E) Oxygen consumption in response to an acute injection of PBS, GCG (0.5 mg/kg), or CL316,243, a selective b-3-adrenergic receptor agonist (1.0 mg/
kg), 8e12 week old Ucp1þ/þ and Ucp1/ mice fed a RCD and housed at RT, n ¼ 6e10. (F) Oxygen consumption following an acute administration of PBS or GCG (0.5 mg/kg) in
12e14 week-old Fgf21þ/þ and Fgf21/ mice fed a RCD and housed at RT, n ¼ 10e11. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. iBAT ¼ interscapular brown
adipose tissue.2 weeks while fed a HFD. Acute GCG administration to mice also
increased oxygen consumption ex vivo in both iBAT and liver explants
(Figure 2D and Figure S2D, respectively). GCG increased oxygen
consumption to similar levels in Ucp1þ/þ vs. Ucp1/ mice, whereas
the response to the b-3-adrenergic receptor agonist (CL316,243) was
blunted in Ucp1/ mice (Figure 2E). As circulating FGF21 levels rose
rapidly following GCG administration (Figure S2E), we assessed the
effect of GCG administration in Fgf21 null mice. In contrast to obser-
vations in Ucp1 null mice, the GCG-induced rise in oxygen consumption
was blunted in Fgf21/ mice compared to Fgf21þ/þ control mice
(Figure 2F), consistent with recent ﬁndings [32].
3.3. Genetic reduction of iBAT Gcgr expression does not regulate
body weight and composition
To determine whether the BAT Gcgr contributes to the physiological
control of energy homeostasis or the acute response to GCG ago-
nism, we crossed Gcgrﬂox/ﬂox with Myf5-Cre mice to generate
GcgrBAT/ mice (Figure 3A). Consistent with the expression domain
of Myf5, levels of Gcgr mRNA transcripts were lower in rWAT and in
BAT from GcgrBAT/ mice, whereas Gcgr expression was not
affected in liver, kidney, and jejunum (Figure 3B, Figure S3A). No
differences in body weight (Figure 3C), fat and lean mass
(Figure 3D), adipose tissue or organ weights (Figure 3E, Figure S3B),
or adipose tissue histology (Figure 3F) were detected in RCD-fed or
in HFD-fed mice (Figure 3GeJ, Figure S3C) housed at RT for 32
weeks. Body temperatures were not different in RCD-fed 8 or 30
week old GcgrBATþ/þ vs. GcgrBAT/ mice after a 16 h overnight fast
or after 30 weeks on RCD or HFD (Figure S3D and S3E). BasalMOLECULAR METABOLISM 22 (2019) 37e48  2019 The Authors. Published by Elsevier GmbH. This is an open ac
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GcgrBATþ/þ and GcgrBAT/ mice after 32 weeks on a RCD
(Figure S3F). Hence, the iBAT Gcgr is dispensable for control of body
weight in response to RCD or HFD-feeding.
3.4. Loss of the iBAT Gcgr does not impact food intake, energy
expenditure, or glucose homeostasis
Food intake, energy expenditure, and the respiratory exchange ratio
(RER) were not different in older GcgrBATþ/þ vs. GcgrBAT/ mice
maintained on RCD (Figure 4AeC) or HFD (Figure 4FeH). Moreover,
acute administration of GCG to GcgrBATþ/þ and GcgrBAT/ mice fed a
RCD did not show any differences in oxygen consumption (Figure 4D).
Activity levels were not different (Figure S4A and S4D) and the levels of
mRNA transcripts for genes regulating thermogenesis or adipose tis-
sue differentiation were similar in adipose tissue depots from RCD- or
HFD-fed GcgrBATþ/þ vs. GcgrBAT/ mice (Figure 4E,I, Figure S4B,C
and S4E,F). Although small increases in plasma GLP-1 and GCG
levels were detected in GcgrBAT/ fed a RCD (Figure S5B and S5F), no
differences in glucose or insulin tolerance, plasma levels of insulin,
GCG, and GIP, or adipose tissue gene expression were detected in
young RCD- or HFD-fed GcgrBATþ/þ vs. GcgrBAT/ mice (Figure S5A-
N). Similarly, oral and intraperitoneal glucose tolerance (Figure 5A,B, I
and 5J), insulin and lipid tolerance (Figure 5C,D, K and L), plasma
levels of TGs and NEFAs (Figure 5E, F, M and N), iBAT TGs (Figure 5G,
O), and the relative levels of mRNA transcripts corresponding to genes
important for lipid and glucose homeostasis (Figure 5H, P) were not
different in older RCD or HFD-fed GcgrBATþ/þ vs. GcgrBAT/ mice
maintained on diets for a longer period of time.cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 41
Figure 3: GcgrBATL/L mice fed RCD or HFD exhibit normal body weight, fat and lean mass, tissue weight, and adipose tissue morphology. (A) Schematic depicting the
generation of GcgrBAT/ mice (B) qPCR analysis of Gcgr mRNA expression in liver and adipose tissues from mice fed a HFD for 32 weeks and housed at RT, n ¼ 4e6. (C) Body
weights in GcgrBATþ/þ and GcgrBAT/ mice (starting at 8e10 weeks of age) fed a RCD and housed at RT, n ¼ 12e19. Fat and lean mass (D), tissue weights relative to body
weight (E), and representative H&E stains of adipose tissue sections, the black bars indicating 100 mM. (F) from GcgrBATþ/þ and GcgrBAT/ mice after 32 weeks of RCD housed at
RT, n ¼ 12e19. (G) Body weights of GcgrBATþ/þ and GcgrBAT/ mice (starting at 8e10 weeks of age) fed a HFD and housed at RT, n ¼ 7e14. Fat and lean mass (H), tissue
weights relative to body weight (I), and representative H&E stains of adipose tissue sections, the black bars indicate 100 mM (J) from GcgrBATþ/þ and GcgrBAT/ mice after 32
weeks of HFD housed at RT, n ¼ 7e14. *p < 0.05. Tbp was used as a housekeeping gene for relative mRNA expression levels. iWAT ¼ inguinal WAT, eWAT ¼ epididymal WAT,
rWAT ¼ retroperitoneal WAT, iBAT ¼ interscapular brown adipose tissue.
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Figure 4: GcgrBATL/L mice fed a RCD or HFD have normal food intake, energy expenditure, and thermogenic and mitochondrial iBAT mRNA expression proﬁles. Food
intake (A), basal energy expenditure (B) and RER (C) measured over 36 h in GcgrBATþ/þ and GcgrBAT/mice housed at RT and fed RCD for 28 weeks (A) or 16 weeks (B, C). n¼ 8e19.
(D) Oxygen consumption following an acute injection of PBS or GCG (0.5 mg/kg) in 8-week old GcgrBATþ/þ and GcgrBAT/ mice fed RCD and housed at rt. n ¼ 8e9. (E) iBAT mRNA
transcript levels for genes regulating thermogenic, mitochondrial, and differentiation processes in GcgrBATþ/þ and GcgrBAT/ mice fed RCD for 32 weeks housed at RT, n ¼ 4e6.
Food intake (F), basal energy expenditure (G) and RER (H) measured over 36 h in GcgrBATþ/þ and GcgrBAT/ mice housed at rt and fed RCD for 28 weeks (F) or 16 weeks (G, H).
n¼ 6e12. (I) iBAT mRNA transcript levels for genes regulating thermogenic, mitochondrial and differentiation processes in GcgrBATþ/þ and GcgrBAT/mice fed HFD for 32 weeks and
housed at RT, n ¼ 4e6. BW ¼ body weight. Tbp was used as a housekeeping gene for relative mRNA expression levels. iBAT ¼ interscapular brown adipose tissue.
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Figure 5: GcgrBATL/L mice fed RCD or HFD have normal glucose, insulin, and lipid tolerance and glucose and lipid iBAT mRNA expression proﬁles. Oral glucose
tolerance (A, I), ip glucose tolerance (B, J), insulin tolerance (C, K), plasma triglycerides (TGs) measured at 0, 1, 2, and 3 h post oral lipid gavage during a lipid tolerance test (LTT;
D, L), plasma TGs (E, M), plasma non-esteriﬁed fatty acids (NEFAs) after an overnight fast and 1 h of refeeding (F, N), iBAT TG levels (G, O), and iBAT mRNA transcript levels of lipid
and glucose regulatory genes (H, P) in GcgrBATþ/þ and GcgrBAT/ mice housed at RT and fed a RCD (AeH) or HFD (IeP) for 22e32 weeks, n ¼ 10e19 for RCD, n ¼ 7e14 for
HFD. *p < 0.05. Tbp was used as a housekeeping gene for relative mRNA expression levels. iBAT ¼ interscapular brown adipose tissue.
Original Article3.5. Normal metabolic adaptation to cold exposure in GcgrBAT/
mice
To determine whether the BAT GCGR is important for the metabolic
adaptation to chronic cold exposure, we studied HFD-fed GcgrBATþ/þ
and GcgrBAT/mice maintained at 4 C forw12 weeks. Body weights
(Figure 6A), fat and lean mass and tissue weights (Figure 6B,C), adipose
tissue morphology (Figure 6D), food intake, energy expenditure, and
respiratory exchange ratio (RER) (Figure 6EeG) were not different be-
tween cold-exposed HFD-fed GcgrBATþ/þ vs. GcgrBAT/ mice.44 MOLECULAR METABOLISM 22 (2019) 37e48  2019 The Authors. Published by Elsevier GmbH. TSimilarly, oral and intraperitoneal glucose tolerance (Figure 6H,I), in-
sulin and lipid tolerance (Figure 6J,K), plasma levels of TGs and NEFAs
(Figure 6L, M), iBAT TGs (Figure 6N) and iBAT gene expression proﬁles
(Figure 6O) were also not different between GcgrBATþ/þ and GcgrBAT/
mice exposed to cold and fed a HFD. Furthermore, body temperature
(Figure S6A), tissue weights (Figure S6B), basal iBAT oxygen con-
sumption (Figure S6C), and activity levels (Figure S6D) were similar in
HFD-fed GcgrBATþ/þ and GcgrBAT/ mice after 10e12 weeks of cold
exposure. Collectively, these results demonstrate that BAT GCGR ishis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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μFigure 6: GcgrBATL/L mice fed a HFD and housed at 4 C exhibit normal glucose, insulin, and lipid tolerance and energy expenditure. Body weights (A), fat and lean
mass (B), tissue weights (C), representative H&E stains of adipose tissue sections, the black bars indicated 100 mM (D), food intake (E), basal energy expenditure measured at RT
(F), basal RER (G), oral (H) and ip (I) glucose tolerance, insulin tolerance (J), plasma triglycerides (TGs) measured at 0, 1, 2, and 3 h post oral lipid gavage during a lipid tolerance
test (LTT; K), plasma TGs (L), plasma non-esteriﬁed fatty acids (NEFAs) after an overnight fast and 1 h of refeeding (M), iBAT TG levels (N), and iBAT mRNA transcript levels of
thermogenic, mitochondrial and lipid/glucose regulatory genes, (O) in GcgrBATþ/þ and GcgrBAT/ mice housed at 4 C and fed a HFD for 2 wks (H), 4 wks (J), 6 wks (I), 8 wks (K),
10 wks (E, F, G), 11 wks (L, M) or 12 wks (A-D, N, O). n ¼ 4e8. *p < 0.05. All mRNA transcript levels were measured relative to levels of the housekeeping gene Tbp.
iWAT ¼ inguinal WAT, eWAT ¼ epididymal WAT, rWAT ¼ retroperitoneal WAT, iBAT ¼ interscapular brown adipose tissue.
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Original Articledispensable for the regulation of energy (food intake, energy expen-
diture, body composition), glucose and lipid metabolism, both in young
and old mice, and in mice fed a RCD, or a HFD, and studied at different
ambient temperatures.
4. DISCUSSION
Considerable experimentation links acute GCG administration to
increased core body temperature [39], BAT blood ﬂow [28], BAT mass,
and thermogenic activity [17,23], as well as enhanced energy expen-
diture in rodents and humans [13,40]. Moreover, several studies have
demonstrated direct actions of GCG on BAT [11,41], raising the possi-
bility that GCGR activity contributes to the endogenous control of whole
body energy expenditure. Herein, we reﬁne the mechanistic importance
of these ﬁndings by using mouse genetics to test the relative importance
of the murine BAT GCGR for the acute response to GCG administration,
and the long term physiological control of energy homeostasis.
Pharmacological GCG agonism produces weight loss through reduction
in food intake and via potentiation of thermogenic mechanisms to in-
crease energy expenditure [3,4]. Indeed, GCG-containing peptide multi-
agonists require a functional GCGR to reduce fat mass and generate
weight loss in HFD-fed mice, actions reﬂecting a combination of
reduced food intake and enhanced energy expenditure [42]. Similarly,
the weight loss observed with the GCG-GLP-1 co-agonist MEDI0382 in
preclinical studies was partially attributed to GCGR-dependent induction
of energy expenditure [43]. Identiﬁcation of the key tissues essential for
the GCGR-dependent control of energy expenditure remains incomplete,
and the available evidence supports a role for multiple organs, including
liver and adipose tissue, in transducing GCGR-stimulated signals linked
to enhanced oxygen consumption [3,32]. Although GCG administration
increased Ucp1 expression in BAT and increased Fgf21 mRNA tran-
scripts in murine liver [12,44], our current data demonstrate that Ucp1
is not required for acute GCG induction of oxygen consumption.
Consistent with recent independent studies, we conﬁrm that the GCG-
induced increase in oxygen consumption is only partially blunted in
Fgf21/ mice [32], implicating additional GCGR-dependent mecha-
nisms contributing to the acute GCG-dependent enhancement of energy
expenditure. Notably, glucagon administration may increase oxygen
consumption in the liver, adipose tissue, and possibly other tissues [31].
Whether these actions, partially independent of FGF21, reﬂect additional
recruitment of downstreammediators, or direct signaling from the GCGR
to mitochondrial pathways, requires further exploration.
Our analysis of relative Gcgr gene expression across a range of tissues
revealed that levels of adipose tissue Gcgr mRNA transcripts were not
abundant, being several orders of magnitude lower in WAT compared to
liver, and even lower in BAT. Nevertheless, acute administration of GCG
to mice increased oxygen consumption not only in the liver, but also in
BAT. Furthermore, our studies with BAT cells in vitro demonstrated that
enhanced or reduced Gcgr expression was associated with the regu-
lation of lipolysis and the expression of genes linked to the control of
energy expenditure. Hence, to identify a role for the BAT Gcgr in the
pharmacological response to acute Gcgr administration in vivo, we
generated and characterized GcgrBAT/ mice. Unexpectedly, GCG
administration robustly induced oxygen consumption to a similar extent
in GcgrBATþ/þ vs. GcgrBAT/ mice. Taken together, these results
suggest that the murine BAT GCGR is not an important molecular target
for the acute pharmacological actions of GCG administration, ﬁndings
consistent with the lack of increased neck temperature or BAT glucose
uptake in healthy male humans following transient GCG infusion [15].
The generation of mice with a marked reduction of BAT Gcgr
expression provided an opportunity to determine the physiological46 MOLECULAR METABOLISM 22 (2019) 37e48  2019 The Authors. Published by Elsevier GmbH. Timportance of the GCGR within the cellular domains targeted by Myf5-
Cre. Notably, the BAT Gcgr is not required for control of body weight,
adiposity, core temperature, or energy expenditure, either when
housed at RT or 4 C. Moreover, we detected no differences in these
parameters in mice maintained on a RCD or HFD. Furthermore, glucose
homeostasis and lipid tolerance was not different in GcgrBATþ/þ vs.
GcgrBAT/ mice, whether maintained in the cold, or at RT and studied
after exposure to RCD or HFD conditions. Hence, the totality of the data
is consistent with the very low level of BAT Gcgr expression and reveals
that the BAT Gcgr is dispensable for metabolic adaptation to energy
excess or a cold environment.
5. LIMITATIONS
Our studies have several limitations. First, we focused on acute
pharmacological GCG administration in young male C57Bl/6 mice
and cannot rule out a role for the BAT GCGR in transduction of a
component of weight loss observed with more sustained GCGR
agonism in a wider range of mice and conditions [32]. Second, we
did not study mice with experimental diabetes; hence, our conclu-
sions are limited to mice analyzed under RCD and HFD feeding.
Third, we did not examine the actions of GCG-containing multi-ag-
onists, and it is possible that BAT GCGR activation may be more
important when GCG is combined with one or more peptides with
complementary metabolic activity. Nevertheless, within the context
of these limitations, the results of our studies are quite conclusive
and suggest that the BAT GCGR is dispensable for the acute
metabolic response to GCG administration and the physiological
control of energy homeostasis.
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